(19)
(11) EP 1 687 029 A1

(12)

(43) Date of publication:
09.08.2006 Bulletin 2006/32

(21) Application number: 03816309.3

(22) Date of filing: 14.11.2003
(51) International Patent Classification (IPC): 
A61K 39/40(2006.01)
C07K 16/00(2006.01)
A61K 39/395(2006.01)
C12P 21/08(2006.01)
(86) International application number:
PCT/US2003/036555
(87) International publication number:
WO 2005/056052 (23.06.2005 Gazette 2005/25)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

(71) Applicant: AVANIR PHARMACEUTICALS
San Diego, California 92121 (US)

(72) Inventors:
  • MORROW, Phillip, R.
    deceased (US)
  • KANG, Angray, S.
    Encinitas, CA 92024 (US)
  • WANG, Fei
    San Diego, CA 92129 (US)
  • JIANG, Ivy
    San Diego, CA 9213 (US)
  • SAWADA-HIRAI, Ritsuko
    San Diego, CA 92130 (US)
  • SCHOLZ, Wolfgang
    San Diego, CA 92129 (US)

(74) Representative: Smaggasgale, Gillian Helen 
W.P. Thompson & Co, 55 Drury Lane
London WC2B 5SQ
London WC2B 5SQ (GB)

   


(54) NEUTRALIZING HUMAN ANTIBODIES TO ANTHRAX TOXIN GENERATED BY RECALL TECHNOLOGY